If there is a man who has excelled in therapy industry, it is none other than Dr. Clay Siegall. He is the founding father of Seattle Genetic, a biotech therapy firm which has gained so much fame among the Seattle community. Dr. Clay Siegall has led this firm to become one of the most reputable firms who develop the most efficient therapy drugs used by millions of people globally. These drugs have enabled many patients to survive long-term illnesses that have not found a cure for the time. His efforts made the firm to develop one of the most popular antibody-drug conjugates which were the first of its type to be approved by the FDA. He was able to steer up the development of more than 20 other drugs with the collaboration of various drug manufacturers.
Dr. Clay Siegall has more faith in his work in that he aims to replace the old models of therapy treatment via a robust combination of technology to adopt an invention of modern equipment and drugs. He has always been interested in the field of medicine since he was a student and this was the motive behind that made him have the idea of developing his business. He was interested in the power of technology, and he knew that when concentrates his skills, he could be able to come up with effective measures to curb fatal diseases like cancer. At one time, he was so much disturbed when a family member became sick and received a brutal chemotherapy process that was so painful where he almost died, and this made Dr. Clay Siegall swear that medicine was his way forward.
Clay Siegall says that his efforts bore fruits after some time as their first drug was efficient and became so popular whereby many people were able to purchase it, and it was approved for three indications. This way he was able to sell the drug and make significant sales. With more commitment and hard work over the time, Seattle Genetics now develops many drugs which they sell and has brought a lot of income to the firm. The firm also gets income fro partnering with several drug manufacturing firms and also leasing, licensing the technologies they have developed and also offering several various procedures that are expensive to the needy patients but also helping them by reducing the cost as his desires it to help patients fight these fatal diseases and live longer.